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OBJECTIVE—In animal studies, hyperglycemia during fetal
development reduces nephron numbers. We tested whether this
observation translates into renal dysfunction in humans by
studying renal functional reserve in adult offspring exposed in
utero to maternal type 1 diabetes.
RESEARCH DESIGN AND METHODS—We compared 19
nondiabetic offspring of type 1 diabetic mothers with 18 offspring
of type 1 diabetic fathers (control subjects). Glomerular ﬁltration
rate (
51Cr-EDTA clearance), effective renal plasma ﬂow (
123I-
hippurate clearance), mean arterial pressure, and renal vascular
resistances were measured at baseline and during amino acid
infusion, which mobilizes renal functional reserve.
RESULTS—Offspring of type 1 diabetic mothers were similar to
control subjects for age (median 27, range 18–41, years), sex,
BMI (23.1  3.7 kg/m
2), and birth weight (3,288  550 vs. 3,440 
489 g). During amino acid infusion, glomerular ﬁltration rate and
effective renal plasma ﬂow increased less in offspring of type 1
diabetic mothers than in control subjects: from 103  14 to 111 
17 ml/min (8  13%) vs. from 108  17 to 128  23 ml/min (19 
7%, P  0.009) and from 509  58 to 536  80 ml/min (5  9%)
vs. from 536  114 to 620  140 ml/min (16  11%, P  0.0035).
Mean arterial pressure and renal vascular resistances declined
less than in control subjects: 2  5 vs. 2  3% (P  0.019) and
3  9 vs. 14  8% (P  0.001).
CONCLUSIONS—Reduced functional reserve may reﬂect a
reduced number of nephrons undergoing individual hyperﬁltra-
tion. If so, offspring of type 1 diabetic mothers may be predis-
posed to glomerular and vascular diseases. Diabetes 59:2631–
2636, 2010
A
reduced number of nephrons may cause hyper-
tension and favor renal and cardiovascular
risks in humans (1). Autopsy ﬁndings support
this assumption (2). In addition, birth weight is
a determinant of nephron numbers in humans (3). In
animal models, moderate hyperglycemia during pregnancy
affects birth weight and nephron numbers in offspring (4),
and favors the development of hypertension in adulthood
(5). In addition, angiogenesis affects kidney development
(6,7). In this respect, moderate hyperglycemia induces a
defect in angiogenesis as reported in experimental condi-
tions (8).
We hypothesized that the effects of moderate hypergly-
cemia on kidney development reported in animal studies
might have clinical relevance in humans. Thus, we studied
kidney function in subjects who had been exposed to
hyperglycemia during their fetal development. For this
purpose, we investigated, as previously (9), adults whose
mothers had type 1 diabetes at the time of their conception
and used the offspring of type 1 diabetic fathers as control
subjects to minimize potential genetic heterogenicity be-
tween groups. Type 1 diabetes as a source of hyperglyce-
mia during fetal development also minimizes confounding
factors associated with type 2 diabetes such as hyperten-
sion. Counting nephron numbers and/or visualizing glo-
merular size by noninvasive methods is not currently
feasible in humans. Thus, we measured global kidney
function at baseline and during vasodilatation produced by
amino acid infusion, i.e., renal functional reserve. Reduc-
tion in renal functional reserve can be interpreted as
reﬂecting a reduced surface available for ﬁltration, sug-
gesting that the number of functional nephrons is reduced.
As a result, the global hemodynamic load provokes hyper-
ﬁltration at the single nephron level (1). This disturbance
in renal hemodynamics was associated with renal and
vascular diseases, both in experimental models (1,4,5) and
clinical settings (10–13). We report here that renal func-
tional reserve is reduced in offspring of type 1 diabetic
mothers.
RESEARCH DESIGN AND METHODS
Case subjects were the direct offspring of type 1 diabetic subjects attending
specialized clinics in ﬁve hospitals in France: Ho ˆpital Saint-Louis, Ho ˆpital
Bichat–Claude Bernard, Ho ˆtel-Dieu (all in Paris), Centre Hospitalier Univer-
sitaire in Poitiers, and Centre Hospitalier Sud Francilien in Corbeil Essonne.
We selected type 1 diabetic parents and then their offspring. Parents had
been diagnosed with type 1 diabetes (as deﬁned by the American Diabetes
Association) at least 2 years before the conception of offspring. Participants
were eligible if their spouses had neither type 1 nor type 2 diabetes at the time
of the study. Mothers were asked if they had smoked during their pregnancies.
Offspring were men or women age 18 years or older with no diabetes. Women
who were pregnant at the time of the investigation were excluded. They were
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antibodies against GAD, IA2, and IA2 ; and anti-insulin antibodies). Chronic
drug intake, acute infection, any chronic disease, and personal or family
history of kidney disease, other than possible diabetic nephropathy in their
diabetic parents, were reasons for exclusion. Case subjects were offspring of
type 1 diabetic mothers, and control subjects were offspring of type 1 diabetic
fathers.
The current study is part of a program investigating the physiologic
consequences of fetal exposure to maternal type 1 diabetes at adult age. We
report here data on kidney function.
At the ﬁrst visit, plasma glucose, insulin, and glucagon concentrations were
measured after an overnight fast with an oral glucose tolerance test. Renal
volume was measured using ultrasounds. Urine was collected for albumin
measurement during 2 h before and after a 20-min exercise on an ergocycle at
an intensity of 80% of maximal heart rate. Then, ambulatory blood pressures
were monitored during the following 24 h.
On a separate occasion, the participants brought 24-h urine for albumin and
sodium measurements, and their kidney function was investigated after an
overnight fast. Glomerular ﬁltration rate (GFR) and renal plasma ﬂow were
measured at baseline and during amino acid infusion using the renal clear-
ances of two radiopharmaceuticals:
51Cr-EDTA (GE Health Care, France), as
an estimate of GFR, and
123I-hippurate (Covidien Imaging, France), as a
measure of effective renal plasma ﬂow (ERPF). A catheter was inserted in a
forearm vein for infusion and another one contralaterally for sampling. The
subjects remained supine for 1 h, after which blood was sampled for plasma
renin and aldosterone measurements. They were given tap water (100 ml
every 15 min) throughout the study to induce a forced water diuresis (mean
10  2 [SD] ml/min). Once diuresis was adequate, the participants received a
primed infusion of both
51Cr-EDTA (bolus 1.8 MBq, then 0.9 MBq/h) and
123I-hippurate (bolus 4 MBq, then 1.5 MBq/h) throughout the study. Two hours
were necessary to obtain a radioisotope plateau and to calculate baseline
clearances of
51Cr-EDTA and
123I-hippurate (the baseline period). Amino acids
(vamine 10%, Fresenius-Kabi, France) were infused at a rate of 5 mg/kg/min
(previously reported as providing maximal renal vasodilatation) (14) after-
ward for the following 90 min (the stimulation period). Plasma and urine
samples were processed to calculate urinary clearances of radiopharmaceu-
ticals. Along the experiment, participants remained supine except when they
voided their bladder every 30 min for urinary sampling. Blood samples were
collected for isotope counting and hematocrit every 30 min, three times before
the end of each period. Mean arterial pressure (MAP) was recorded using an
automatic device (Dinamap, France).
All aspects of the study were approved by the Ethical Committee of Paris
Saint-Louis. Each participant signed a written informed consent to participate.
Measurements. Kidney volume was measured with ultrasounds (Siemens
Elegra SSN 7083, Germany) using a previously published method (15).
Urinary albumin was measured using a nephelometric method (Behring test,
Marburg, Germany, assay sensitivity 2 mg/l and intra- and interassay variability of
5 and 7%, respectively). Glucose was measured with glucose oxidase and insulin,
glucagon, renin, and aldosterone with radioimmunoassays.
Isotope counting was performed using a gamma counter (1480 Wizard 3,
Perkin Elmer).
Calculations. Renal clearances of isotopes were calculated as urine volume
multiplied by urine isotope concentration, divided by plasma isotope concen-
tration. The ﬁrst 60 min of the basal period and the ﬁrst 30 min of the
stimulation period were not used for calculations because a steady state could
not be assumed for plasma isotopes and amino acids. Thus, renal clearances
of isotopes were calculated from the mean of the two measurements
performed 30 min apart at the end of each period. The GFR and ERPF values
were not corrected for body surface. Filtration fraction (FF) was calculated as
GFR divided by ERPF. To determine MAP values, blood pressures were
recorded every 5 min and their mean for each 30-min clearance period. Renal
vascular resistances (RVRs) were calculated from MAP/(ERPF/[1  hemato-
crit]). The mean intrasubject variability for the basal periods were 4.2% for
GFR, 3.5% for ERPF, 4.3% for FF, 2.2% for MAP, and 4.9% for RVR. For the
stimulated periods, they were, respectively, 4.9% for GFR, 4.2% for ERPF, 3.9%
for FF, 1.8% for MAP, and 4.9% for RVR. The renal functional reserve was
calculated as the percentage change in each of the studied variables from the
basal period to the stimulated period.
Statistical analysis. Data are presented as mean  SD, median (range), or
percentages. The primary end point was the intergroup difference in GFR
changes produced by amino acid infusion. The assumption was that a 20%
increase in GFR (SD 10%) would be observed during infusion in control
subjects and that the mean increase would be 50% less in offspring of type 1
diabetic mothers. With a type 1 error rate of 5%, 21 subjects per group were
required to test the hypothesis with a 90% power. For technical reasons, only
experiments performed in 19 case subjects and 18 control subjects could be
analyzed.
Intragroup changes were analyzed by paired t tests or signed Wilcoxon
rank-sum tests and intergroup comparisons by modiﬁed Welsh t tests or
Mann-Whitney tests. Parametric or nonparametric tests were chosen by
assessing whether the data distribution was skewed. The correlation between
renal hemodynamic changes and birth weight was assessed by the Pearson
correlation coefﬁcient. The hypothesis of a different correlation in case
subjects and control subjects was tested by an interaction test in a linear
model. The threshold for P value signiﬁcance was set at 0.05.
Statistical analysis was performed using R 2.6.2 (The R Foundation for
Statistical Computing, Vienna, Austria) statistical software.
RESULTS
Participant recruitment and characteristics. Among
approximately 2,000 type 1 diabetic subjects attending the
ﬁve clinics, 102 were eligible, 83 agreed to contact their
offspring, and 62 offspring agreed to participate in our
program investigating the physiologic consequences of
fetal exposure to maternal type 1 diabetes in adulthood. A
total of 41 subjects (21 case subjects, 20 control subjects)
agreed to undergo renal tests. They did not differ from the
21 other subjects. Four participants (2 in each group) were
excluded from analyses for technical reasons (they vom-
ited during amino acid infusions).
The characteristics of the participants’ parents are given
in Table 1. None of the mothers smoked during their
pregnancies.
The characteristics of participants are given in Table 2.
There was no intergroup difference for age or sex distri-
bution. As anticipated, gestational age at delivery was
lower in case subjects than in control subjects. Con-
versely, birth weights did not differ. Birth weights did not
differ after adjustment for gestational age: 3,535  5 1 6gi n
case subjects vs. 3,404  430 g in control subjects. The
BMIs were identical. Fasting plasma glucose, insulin, and
glucagon were similar and within normal range. One case
subject and two control subjects displayed impaired glu-
cose tolerance during the oral glucose tolerance test.
During the exercise test, systolic/diastolic blood pres-
sures increased similarly in the two groups: from 116 
14/71  14 mmHg to 127  15/71  12 mmHg in case
subject vs. from 118  16/68  12 mmHg to 126  14/70 
10 mmHg in control subjects. Urinary albumin excretions
varied similarly: from 2 (range 2–20) to 35 (5–810) g/min
in case subjects vs. from 2 (2–3) to 64 (4–312) g/min in
control subjects. The 24-h ambulatory blood pressures
were not different, showing diurnal and nocturnal blood
pressures, respectively, at 117  10/71  4 mmHg and
114  4/64  8 mmHg in case subjects and 118  8/72 
7 mmHg and 113  8/66  7 mmHg in control subjects.
Kidney volumes were similar in both groups (Table 2).
No morphologic anomaly was detected in the kidneys and
urinary tracts during ultrasound examination.
TABLE 1
Characteristics of the parents of the case subjects
Type 1 diabetic
mothers
Type 1 diabetic
fathers
n 19 18
Current age (years) 53 (50–65) 55 (45–65)
Age at diabetes onset (years) 12 (4–24) 16 (3–33)
Age at offspring conception
(years) 28 (19–35) 29 (25–41)
Number of patients with
nephropathy 3 4
Data are medians (range). Nephropathy was deﬁned as present or
past clinical proteinuria.
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excretions were slightly but not statistically higher in case
subjects than in control subjects. Although urinary excre-
tions of sodium, potassium, and plasma renin were similar
between groups, plasma aldosterone was higher in case
subjects than in control subjects. However, the plasma
renin/aldosterone ratio was similar (Table 3).
The individual changes in renal parameters are given in
Fig. 1. Although the baseline GFR values did not differ,
they increased less in response to amino acids in case
subjects compared with control subjects: from 102  14 to
111  17 ml/min (8  13%, P  0.019) vs. from 108  17 to
128  23 ml/min (19  7%, P  0.002, intergroup difference
P  0.009, Fig. 1A). The ERPF changes also increased less
in response to amino acids in case subjects compared with
control subjects: from 509  58 to 536  114 ml/min (5 
9%, P  0.016) vs. from 536  114 to 620  140 ml/min
(16  11%, P  0.002; intergroup difference P  0.0035,
Fig. 1B). The baseline FFs (0.20  0.03 in case subjects vs.
0.21  0.03 in control subjects) were not altered: 3  8%
(P  0.14) vs. 3  11% (P  0.26; intergroup difference P 
0.92, Fig. 1C). In case subjects, MAP varied from 88  6t o
91  8 mmHg (2  5%, P  0.061), whereas it declined
from 86  6t o8 4 5 mmHg in control subjects (2  3%,
P  0.029; intergroup difference P  0.019, Fig. 1D).
Consequently, RVR in case subjects did not vary: from
0.113  0.015 to 0.110  0.017 mmHg/ml/min (3  9%,
P  0.1), whereas they declined from 0.106  0.024 to
0.091  0.019 mmHg/ml/min in control subjects (14 
8%, P  0.002, intergroup difference P  0.001, Fig. 1E).
We examined the relationship between renal hemody-
namic changes and birth weight. It was signiﬁcantly dif-
ferent in case subjects compared with control subjects
(P  0.009): the relationship between changes in GFR
during amino acid infusion and birth weight was highly
signiﬁcant in case subjects (r  0.61, P  0.006), but not in
control subjects (r  0.08, P  0.78, Fig. 2). These
analyses were not altered when birth weight was adjusted
for gestational age. The relationship was not different
according to sex (P  0.70). There was no association
between height and changes in GFR (r  0.27; 95% CI
0.06 to 0.54, P  0.11).
DISCUSSION
We found that fetal exposure to maternal type 1 diabetes
was associated with a reduced renal reserve in offspring of
humans at adult age. Our results in humans are consistent
with what has been observed in rats regarding the impact
of moderate hyperglycemia during fetal development on
adult kidney dysfunction (5). They suggest a reduced
number of nephrons in offspring of type 1 diabetic moth-
ers, even though the precise quantiﬁcation was not per-
formed, as noninvasive methods are not currently
available in humans. We recognize that a reduced func-
tional reserve does not mean a reduced nephron number
in the absence of direct association in humans. However,
a reduced functional reserve in humans indicates an
already dilated renal vasculature resulting in global hyper-
ﬁltration, or an already established glomerular disease
with reduced glomerular ﬁltration rate (10). Mogensen and
Christensen (12) reported that in type 1 diabetes, global
hyperﬁltration is predictive of clinical proteinuria, and
Sackmann et al. (13) reported a reduced functional reserve
both in normotensive, normoalbuminuric subjects with
recent type 1 diabetes (those prone to nephropathy dis-
played global hyperﬁltration), and in proteinuric subjects
with long-lasting type 1 diabetes (those with an already
TABLE 2
Characteristics of the case subjects (part one)
Offspring of type 1 diabetic mothers Offspring of type 1 diabetic fathers P
n 19 18
Sex (male/female) 5/14 9/9 0.18
Age (years)* 24 (18–41) 25 (18–37) 0.96
Gestational age at delivery (weeks)* 37 (33–40) 40 (37–40) 0.0004
Birth weight (g)* 3,200 (2,750–4,270) 3,300 (2,700–4,540) 0.29
BMI (kg/m
2)* 22.6 (17.9–29.9) 22.4 (19–27.7) 0.58
Fasting plasma glucose (mmol/l)† 4.5  0.4 4.5  0.3 0.86
Fasting plasma insulin (U/ml)† 5.0  1.6 4.6  2.2 0.56
Fasting plasma glucagon (pg/ml)† 130.4  28.1 151.1  41.1 0.13
Kidney volume (ml)†
Right kidney 157.0  35.5 165.0  42.2 0.65
Left kidney 155.9  34.0 151.1  18.6 0.71
Data are counts, *medians (range), or †means  SD.
TABLE 3
Characteristics of the case subjects at the time of renal tests (part two)
Offspring of type 1 diabetic mothers Offspring of type 1 diabetic fathers P
n 19 18
Systolic BP/diastolic BP (mmHg)* 118  6/72  7 114  7 /70  8 0.085/0.36
Urinary sodium (mmol/24 h)* 136  78 131  66 0.84
Urinary potassium (mmol/24 h)* 82  58 72  54 0.59
Urinary albumin (mg/24 h)† 9 (5–14) 5 (4–8) 0.11
Plasma renin (pg/ml)† 7 (3–78) 7 (3–26) 0.75
Plasma aldosterone (pg/ml)† 109.6 (56.5–138) 63.1 (35.8–83) 0.036
Renin/aldosterone ratio† 0.15 (0.01–0.78) 0.15 (0.02–0.29) 0.30
Data are *means  SD or †medians (range). BP, blood pressure.
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studied by these authors were on ACE inhibitors, making
data interpretation difﬁcult, since ACE inhibitors can alter
kidney function of such patients (16), and since renal
functional reserve can be altered by these drugs (17).
Studies conducted in animals (18,19) support the view that
the glomeruli of subjects such as those with reduced
functional reserve undergo individual hyperﬁltration, a
hemodynamic condition that favors glomerulosclerosis,
hypertension, and high renovascular risk (1,11). The pos-
sibility that permanent hyperﬁltration occurs within each
nephron of the offspring of type 1 diabetic mothers is
supported here by the lack of intergroup difference for
baseline GFR, whereas the renal vasodilatation produced
by amino acid infusion was severely reduced in case
subjects compared with control subjects. In rats, a re-
duced number of nephrons provoked by hyperglycemia
during fetal development favors salt-sensitive hyperten-
sion in adulthood (5). Salt-sensitive hypertension was
related to glomerular dysfunction in human studies (20).
Here we found no difference for blood pressures or urinary
albumin excretions, but our study was not powered to
determine such differences. Conversely, a large prospec-
tive study in Denmark reported that offspring of type 1
diabetic mothers displayed elevated systolic blood pres-
sures (21), but their kidney function was not studied. Also,
Pima Indians with type 2 diabetes exposed in utero to
maternal diabetes developed microalbuminuria and higher
blood pressure more frequently than those who were not
exposed (22). Thus, large-scale studies are now required
on blood pressure and albuminuria of the offspring of type
1 diabetic mothers. Note that we did not replicate our
initial ﬁndings regarding glucose tolerance in the offspring
of type 1 diabetic mothers (9). Since this earlier report,
several public health interventions have been conducted in
France to reduce the incidence of obesity and diabetes.
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FIG. 1. Kidney function of offspring of type 1 diabetic mothers (case subjects, left) and of offspring of type 1 diabetic fathers (control subjects,
right) in basal conditions and during infusion of amino acids (stimulated). Data are given as median values with box plots and individual values.
A: Changes in glomerular ﬁltration rate (GFR), intragroup changes in case subjects: 8  13%, P  0.019, and in control subjects: 19  17%, P 
0.002, intergroup comparison: P  0.009. B: Changes in effective renal plasma ﬂow (ERPF), intragroup changes in case subjects: 5  9%, P 
0.016, and in control subjects: 16  11%, P  0.002, intergroup comparison: P  0.0035. C: Changes in FF, intragroup changes in case subjects:
3  8%, P  0.14, and in control subjects: 3  8%, P  0.26, intergroup comparisons: P  0.92. D: Changes in mean arterial pressure (MAP),
intragroup changes in case subjects: 2  5%, P  0.061, and in control subjects: 2  3%, P  0.029, intergroup comparison: P  0.019. E: Changes
in renal vascular resistances (RVR), intragroup changes in case subjects: 3  9%, P  0.1, and in control subjects: 14  8%, P  0.002,
intergroup comparison: P  0.001.
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sensitive to these measures (their mean BMI was 22.5
kg/m
2, thereby reducing their risk for glucose intolerance).
Also, the present study was not sized to address the issue
of glucose intolerance in the participants.
The role of birth weight on kidney function in adulthood
must be delineated. Hughson et al. (3) reported in an
autopsy study an association between birth weight and
glomerular number and size. Here we observed a positive
correlation between renal functional reserve and birth
weight in the offspring of type 1 diabetic mothers, but not
in control subjects, despite similar birth weight. Thus,
birth weight may inﬂuence kidney function in adulthood
only in subjects exposed in utero to maternal diabetes.
Moderate hyperglycemia during fetal development may be
necessary for birth weight to affect adult kidney function.
We studied offspring of type 1, rather than type 2,
diabetic mothers (22), taking offspring of type 1 diabetic
fathers as control subjects as we did earlier (9), to avoid
confusion because of the genetic background of hyperten-
sion, a condition linked both to kidney disease and to type
2 diabetes. Thus, our study supports a direct impact of
hyperglycemia or its associated metabolic abnormalities
(23–25) during fetal development on kidney dysfunction
later in life.
We could not establish a relationship between the level
of hyperglycemia during pregnancy and kidney dysfunc-
tion at adulthood. Uncontrolled hyperglycemia in type 1
diabetic mothers promotes renal malformations in off-
spring (26). None of our participants had morphologic
kidney anomalies. The average term for delivery of type 1
diabetic mothers was 37 weeks (range 33–40) without
frank macrosomia or microsomia, and birth weights were
not different between the groups, suggesting optimized
blood glucose control. However, we could not retrospec-
tively quantify the level of glycemic control attained during
these pregnancies. Half of them occurred before 1980, a
time when neither glycated hemoglobin nor self-monitor-
ing of blood glucose was available for diabetes care.
Hyperglycemia induces several biochemical and hemody-
namic abnormalities (23–25) that may account for the renal
changes reported here. In rats, exposure in utero to hyper-
glycemia and reduced nephron numbers in offspring (4) was
associated with alterations of the expressions of insulin-like
growth factors and their receptors in fetal kidney (27).
Alterations in angiogenesis may also be plausible. In the
model of chicken chorioallantoic membrane, we did not ﬁnd
that high glucose levels altered the expression of several
growth factors involved in angiogenesis, but increased apop-
tosis and decreased proliferation of endothelial cells oc-
curred (8). Whether hyperglycemia during fetal development
provokes epigenetic alterations leading to renal dysfunction
in adulthood remains to be elucidated (28).
Plasma aldosterone was higher in case subjects than in
control subjects, whereas plasma renin did not differ signif-
icantly. These data are exploratory, and they may be due to
a type 1 error. However, such a ﬁgure is often encountered in
people with a volume-dependent hypertension (29). We
found no relationship between plasma aldosterone, renin,
and sodium or potassium urinary excretions or blood pres-
sure values (data not shown). However, we did not measure
extracellular volumes of the participants to this study, and
sodium intake was not controlled. Further investigations are
required in this respect. Interestingly, epigenetic modiﬁca-
tions of the renin-angiotensin system were reported in exper-
imental settings (30), and an inverse relationship was
reported between birth weight and plasma aldosterone at
adult age in humans (31).
In conclusion, this study supports that moderate hyper-
glycemia (or its related metabolic alterations) during fetal
development may alter kidney function in human adults.
As pregnancy is now common in type 1 diabetic women,
we will have to pay attention to the renal and vascular
status of their offspring during adulthood.
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